1 asset in Oculocerebrorenal Syndrome
Therapeutic assets addressing Oculocerebrorenal Syndrome, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Piclidenoson Oculocerebrorenal Syndrome | Can-Fite BioPharma | P2 | NR () |